SITC 2021 - Peptidyl IL-2/15Rβγc-restricted agonists, highly-attenuated and linked to anti-PD-1 antibodies to achieve selectivity and amplify potency in stimulating PD-1 high lymphocytes

Previous
Previous

AACR 2022 – In vitro and in vivo properties of MDK-703, An Fc-peptide fusion IL-7Rαγc agonist unrelated in structure to IL-7

Next
Next

SITC 2020 - MDK-701, a potent peptidyl agonist of IL-7R fused to an FC-domain